Menquadfi vial 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7P2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,236
Award facts
- Contract value 100% obligated
- $29,236.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,236 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Menquadfi vials (0.5ML). This is a non-set-aside contract with a completion date of January 13, 2026, and the place of performance is located in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and runs through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, and operates as a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4). The company has demonstrated capability to meet federal procurement requirements through open competition, with contract awards consistently involving delivery orders and firm fixed pricing across multiple therapeutic domains. This delivery order for Menquadfi vaccine vials supports the Defense Health Agency and other government healthcare systems serving military personnel and veterans through DLA's medical supply chain network.
Quick answers
Who was awarded contract SPE2DR26FV7P2?
SPE2DR26FV7P2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV7P2 worth?
The government has obligated $29,236 on SPE2DR26FV7P2.
Is contract SPE2DR26FV7P2 an order under another contract?
Yes. SPE2DR26FV7P2 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7P2 competed?
The extent of competition for SPE2DR26FV7P2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award